The effects of octreotide in dilated cardiomyopathy - An open-label trial in 12 patients

Creative Commons License

Eryol N. K., Guven M., Topsakal R., Sungur M., Ozdogru I., Inanc T., ...Daha Fazla

JAPANESE HEART JOURNAL, cilt.45, sa.4, ss.613-621, 2004 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 45 Sayı: 4
  • Basım Tarihi: 2004
  • Doi Numarası: 10.1536/jhj.45.613
  • Dergi Adı: JAPANESE HEART JOURNAL
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.613-621
  • Anahtar Kelimeler: dilated cardiomyopathy, octreotide, CONGESTIVE-HEART-FAILURE, IGF-I AXIS, GROWTH-HORMONE, SOMATOSTATIN ANALOG, EXERCISE CAPACITY, GUINEA-PIG, IMPROVEMENT, HYPERTROPHY, MECHANISMS, THERAPY
  • Lokman Hekim Üniversitesi Adresli: Hayır

Özet

Octreotide, a somatostatin analogue, has been found effective in the treatment of acromegalic cardiomyopathy. We investigated whether intermittent octreotide therapy had beneficial effects in patients with ischemic or idiopathic dilated cardiomyopathy, which are refractory to conventional therapy.